15 results
20-F
2020 FY
EX-2.5
GRCL
Gracell Biotechnologies Inc
23 Apr 21
Annual report (foreign)
4:04pm
of the minority to promote interests adverse to those of the class;
the arrangement is such that may be reasonably approved by an intelligent … ” of dissentient minority shareholder upon a tender offer. When a tender offer is made and accepted by holders of 90.0% of the shares affected within four
20-F
2020 FY
GRCL
Gracell Biotechnologies Inc
23 Apr 21
Annual report (foreign)
4:04pm
and other minority shareholders from influencing significant corporate decisions and may result in conflicts of interest.
As of March 31, 2021, Dr … . The rights of shareholders to take action against our directors, actions by our minority shareholders and the fiduciary responsibilities of our
424B4
GRCL
Gracell Biotechnologies Inc
8 Jan 21
Prospectus supplement with pricing info
1:42pm
minority shareholders from influencing significant corporate decisions and may result in conflicts of interest.
Implications of Being an Emerging Growth … , where applicable.
If the ownership of our shares continues to be highly concentrated, it may prevent you and other minority shareholders from
F-1/A
etkchfxbokd
7 Jan 21
Registration statement (foreign) (amended)
7:03am
F-1/A
hqfrdfmj6f
6 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1/A
vldogi
4 Jan 21
Registration statement (foreign) (amended)
9:30am
F-1
EX-3.1
yyeboxubn q5w
18 Dec 20
Registration statement (foreign)
4:18pm
F-1
EX-4.4
ks5eme
18 Dec 20
Registration statement (foreign)
4:18pm
F-1
jjfh6kdavbk7mb40
18 Dec 20
Registration statement (foreign)
4:18pm
DRS/A
jn2p toe41
24 Nov 20
Draft registration statement (amended)
12:00am
DRS/A
EX-3.1
sngr6pyshaexpkl7y
24 Nov 20
Draft registration statement (amended)
12:00am
DRS/A
EX-4.4
aus9sv3ulr6lw
24 Nov 20
Draft registration statement (amended)
12:00am
DRS
0hta29kl8sc qtk
19 Oct 20
Draft registration statement
12:00am
- Prev
- 1
- Next